Gainers
- Ventyx Biosciences (NASDAQ:VTYX) shares moved upwards by 61.0% to $37.18 during Monday's regular session. The current volume of 12.9 million shares is 4790.0% of Ventyx Biosciences's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $1.8 billion.
- Clovis Oncology (NASDAQ:CLVS) stock moved upwards by 33.92% to $1.54. Clovis Oncology's stock is trading at a volume of 21.1 million shares as of 13:30 EST. This is 175.8% of its average full-day volume over the last 100 days. The company's market cap stands at $222.5 million.
- Regulus Therapeutics (NASDAQ:RGLS) shares moved upwards by 27.97% to $2.15. As of 13:30 EST, Regulus Therapeutics's stock is trading at a volume of 40.3 million, which is 13295.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $31.4 million.
- IDEAYA Biosciences (NASDAQ:IDYA) stock increased by 27.23% to $11.77. As of 13:30 EST, IDEAYA Biosciences's stock is trading at a volume of 1.5 million, which is 474.0% of its average full-day volume over the last 100 days. The company's market cap stands at $462.5 million.
- Annovis Bio (NYSE:ANVS) shares rose 24.83% to $19.1. As of 13:30 EST, Annovis Bio's stock is trading at a volume of 355.2K, which is 458.5% of its average full-day volume over the last 100 days. The company's market cap stands at $155.9 million.
- ImmunityBio (NASDAQ:IBRX) shares increased by 18.1% to $5.48. ImmunityBio's stock is trading at a volume of 2.5 million shares as of 13:30 EST. This is 175.2% of its average full-day volume over the last 100 days. The company's market cap stands at $2.1 billion.
Losers
- Akari Therapeutics (NASDAQ:AKTX) stock decreased by 26.0% to $0.77 during Monday's regular session. Trading volume for this security as of 13:30 EST is 644.7K, which is 981.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $45.6 million.
- Entrada Therapeutics (NASDAQ:TRDA) shares decreased by 17.97% to $12.24. As of 13:30 EST, this security is trading at a volume of 59.0K shares, making up 65.2% of its average full-day volume over the last 100 days. The company's market cap stands at $383.9 million.
- Leap Therapeutics (NASDAQ:LPTX) shares declined by 17.76% to $1.39. Trading volume for Leap Therapeutics's stock is 1.7 million as of 13:30 EST. This is 285.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $137.6 million.
- DICE Therapeutics (NASDAQ:DICE) shares decreased by 13.51% to $19.59. As of 13:30 EST, this security is trading at a volume of 1.6 million shares, making up 446.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $748.5 million.
- AnPac Bio-Medical Science (NASDAQ:ANPC) stock declined by 12.96% to $0.17. Trading volume for AnPac Bio-Medical Science's stock is 649.0K as of 13:30 EST. This is 24.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $6.8 million.
- AN2 Therapeutics (NASDAQ:ANTX) stock decreased by 12.92% to $8.23. The market value of their outstanding shares is at $159.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
